These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 21765081)

  • 21. Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes.
    Amidi M; van Helden MJ; Tabataei NR; de Goede AL; Schouten M; de Bot V; Lanzi A; Gruters RA; Rimmelzwaan GF; Sijts AJ; Mastrobattista E
    J Control Release; 2012 Dec; 164(3):323-30. PubMed ID: 22940204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical DNA vaccination with DNA/Lipid based complex.
    Choi MJ; Kim JH; Maibach HI
    Curr Drug Deliv; 2006 Jan; 3(1):37-45. PubMed ID: 16472092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization and delivery of plasmid DNA for vaccination.
    Jechlinger W
    Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.
    Moore AC; Kong WP; Chakrabarti BK; Nabel GJ
    J Virol; 2002 Jan; 76(1):243-50. PubMed ID: 11739689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques.
    Todorova B; Adam L; Culina S; Boisgard R; Martinon F; Cosma A; Ustav M; Kortulewski T; Le Grand R; Chapon C
    Sci Rep; 2017 Jun; 7(1):4122. PubMed ID: 28646234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccines.
    Montgomery DL; Ulmer JB; Donnelly JJ; Liu MA
    Pharmacol Ther; 1997; 74(2):195-205. PubMed ID: 9336022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled delivery of antigens and adjuvants in vaccine development.
    Zhao Z; Leong KW
    J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical vaccination of DNA antigens: topical delivery of DNA antigens.
    Choi MJ; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):271-82. PubMed ID: 12907832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal vaccination by DNA tattooing.
    van den Berg JH; Oosterhuis K; Schumacher TN; Haanen JB; Bins AD
    Methods Mol Biol; 2014; 1143():131-40. PubMed ID: 24715286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic adjuvants for DNA vaccines.
    Scheerlinck JY
    Vaccine; 2001 Mar; 19(17-19):2647-56. PubMed ID: 11257404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.
    Hutnick NA; Myles DJ; Ferraro B; Lucke C; Lin F; Yan J; Broderick KE; Khan AS; Sardesai NY; Weiner DB
    Hum Gene Ther; 2012 Sep; 23(9):943-50. PubMed ID: 22650607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.
    Karlsson I; Borggren M; Nielsen J; Christensen D; Williams J; Fomsgaard A
    Hum Vaccin Immunother; 2017 Aug; 13(8):1823-1830. PubMed ID: 28613978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jump-starting the immune system: prime-boosting comes of age.
    Woodland DL
    Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleic acid vaccines: tasks and tactics.
    McKenzie BS; Corbett AJ; Brady JL; Dyer CM; Strugnell RA; Kent SJ; Kramer DR; Boyle JS; Lew AM
    Immunol Res; 2001; 24(3):225-44. PubMed ID: 11817323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating specific priming of immune effector functions by DNA-based vaccination strategies.
    Reimann J; Schirmbeck R
    Dev Biol (Basel); 2000; 104():15-24. PubMed ID: 11713813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for improving DNA vaccine performance.
    Iurescia S; Fioretti D; Rinaldi M
    Methods Mol Biol; 2014; 1143():21-31. PubMed ID: 24715280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation.
    Vandermeulen G; Vanvarenberg K; De Beuckelaer A; De Koker S; Lambricht L; Uyttenhove C; Reschner A; Vanderplasschen A; Grooten J; Préat V
    Vaccine; 2015 Jun; 33(28):3179-85. PubMed ID: 25980430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccines: developing new strategies to enhance immune responses.
    Abdulhaqq SA; Weiner DB
    Immunol Res; 2008; 42(1-3):219-32. PubMed ID: 19066740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.